Fritz Julie M, King Jordan B, McAdams-Marx Carrie
Department of Physical Therapy & Athletic Training, College of Health, University of Utah, Salt Lake City, UT.
Department of Pharmacy, Kaiser Permanente Colorado, Denver, CO.
Clin J Pain. 2018 Jun;34(6):552-558. doi: 10.1097/AJP.0000000000000571.
The aim of this study was to identify associations between early care decisions and long-term opioid (LTO) use in opioid-naïve patients with a new physician consultation for low back pain (LBP) at which an opioid was prescribed.
A retrospective study of claims data was used to identify opioid-naïve LBP patients who were prescribed opioids at the index physician visit. Early care variables captured included additional nonopioid medications prescribed within 14 days and provider visits or diagnostic imaging within 30 days of the index visit. A multivariate logistic model was used to identify early care variables associated with the outcome of (LTO) use in the year following the index visit controlling for patient factors.
A total of 707 patients were included in this study. The mean age was 38.1 (±11.6), and 67.8% were female individuals and 76.9% were Medicaid beneficiaries. Early care medications were muscle relaxants (32.2%), nonsteroidal anti-inflammatories (29.3%), oral steroids (11.7%), and benzodiazepines (8.3%). The most common early care provider visits were with primary care (31.0%) and physical therapy (13.0%). A total of 172 patients (24.3%) progressed to LTO use. Controlling for patient factors, early care variables increasing risk for LTO use were an early benzodiazepine prescription and primary care visit. An early physical therapy visit was associated with reduced risk for LTO use.
Early care decisions were predictive of LTO use following a new LBP consultation at which opioids were prescribed. Our results support recommendations to avoid concurrent benzodiazepine prescribing and to consider other evidence-based pain treatments such as physical therapy early, particularly for patients at high risk for LTO use or misuse.
本研究旨在确定在因腰痛(LBP)首次就诊并开具阿片类药物处方的阿片类药物初治患者中,早期护理决策与长期阿片类药物(LTO)使用之间的关联。
采用回顾性索赔数据研究,以确定在首次就诊时开具阿片类药物的阿片类药物初治LBP患者。记录的早期护理变量包括在14天内开具的其他非阿片类药物,以及在首次就诊后30天内的医疗服务提供者就诊或诊断性影像学检查。使用多变量逻辑模型确定与首次就诊后一年内LTO使用结果相关的早期护理变量,并对患者因素进行控制。
本研究共纳入707例患者。平均年龄为38.1岁(±11.6),67.8%为女性,76.9%为医疗补助受益人。早期护理用药包括肌肉松弛剂(32.2%)、非甾体抗炎药(29.3%)、口服类固醇(11.7%)和苯二氮䓬类药物(8.3%)。最常见的早期护理提供者就诊是初级保健(31.0%)和物理治疗(13.0%)。共有172例患者(24.3%)进展为LTO使用。在控制患者因素的情况下,增加LTO使用风险的早期护理变量是早期苯二氮䓬类药物处方和初级保健就诊。早期物理治疗就诊与LTO使用风险降低相关。
早期护理决策可预测在因LBP首次就诊并开具阿片类药物处方后LTO的使用情况。我们的结果支持以下建议:避免同时开具苯二氮䓬类药物,并尽早考虑其他循证疼痛治疗方法,如物理治疗,尤其是对于有LTO使用或滥用高风险的患者。